These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 31242658)

  • 1. Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis.
    Zhang J; Tang PMK; Zhou Y; Cheng ASL; Yu J; Kang W; To KF
    Cells; 2019 Jun; 8(6):. PubMed ID: 31242658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
    Dianat-Moghadam H; Teimoori-Toolabi L
    Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential.
    Zhang J; Wong CC; Leung KT; Wu F; Zhou Y; Tong JHM; Chan RCK; Li H; Wang Y; Yan H; Liu L; Wu WKK; Chan MWY; Cheng ASL; Yu J; Wong N; Lo KW; To KF; Kang W
    Oncogene; 2020 Oct; 39(43):6647-6663. PubMed ID: 32934314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF signaling network in the gastrointestinal tract (review).
    Katoh M; Katoh M
    Int J Oncol; 2006 Jul; 29(1):163-8. PubMed ID: 16773196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
    Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H
    J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer.
    Shin EY; Lee BH; Yang JH; Shin KS; Lee GK; Yun HY; Song YJ; Park SC; Kim EG
    J Cancer Res Clin Oncol; 2000 Sep; 126(9):519-28. PubMed ID: 11003564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF/FGFR signaling in bone formation: progress and perspectives.
    Marie PJ; Miraoui H; Sévère N
    Growth Factors; 2012 Apr; 30(2):117-23. PubMed ID: 22292523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [FGF/FGFR signalling: Implication in oncogenesis and perspectives].
    Flippot R; Kone M; Magné N; Vignot S
    Bull Cancer; 2015 Jun; 102(6):516-26. PubMed ID: 25986739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
    Helsten T; Schwaederle M; Kurzrock R
    Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation of FGF/FGFR: An underrated sweet code regulating cellular signaling programs.
    Gędaj A; Gregorczyk P; Żukowska D; Chorążewska A; Ciura K; Kalka M; Porębska N; Opaliński Ł
    Cytokine Growth Factor Rev; 2024 Jun; 77():39-55. PubMed ID: 38719671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression.
    Li Q; Ingram L; Kim S; Beharry Z; Cooper JA; Cai H
    Neoplasia; 2018 Mar; 20(3):233-243. PubMed ID: 29444487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule inhibition of fibroblast growth factor receptors in cancer.
    Liang G; Chen G; Wei X; Zhao Y; Li X
    Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutics Targeting FGF Signaling Network in Human Diseases.
    Katoh M
    Trends Pharmacol Sci; 2016 Dec; 37(12):1081-1096. PubMed ID: 27992319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p.
    Zhang J; Zhou Y; Huang T; Wu F; Pan Y; Dong Y; Wang Y; Chan AKY; Liu L; Kwan JSH; Cheung AHK; Wong CC; Lo AKF; Cheng ASL; Yu J; Lo KW; Kang W; To KF
    Oncogene; 2019 Jan; 38(1):33-46. PubMed ID: 30082912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fibroblast growth factors and their receptors in prostate cancer.
    Kwabi-Addo B; Ozen M; Ittmann M
    Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention.
    Mahapatra S; Jonniya NA; Koirala S; Ursal KD; Kar P
    J Biomol Struct Dyn; 2023; 41(22):13509-13533. PubMed ID: 36995019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
    Ronca R; Giacomini A; Rusnati M; Presta M
    Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma.
    Tamburello M; Altieri B; Sbiera I; Sigala S; Berruti A; Fassnacht M; Sbiera S
    Endocrine; 2022 Sep; 77(3):411-418. PubMed ID: 35583844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and challenges in targeting FGFR signalling in cancer.
    Babina IS; Turner NC
    Nat Rev Cancer; 2017 May; 17(5):318-332. PubMed ID: 28303906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.
    Giacomini A; Chiodelli P; Matarazzo S; Rusnati M; Presta M; Ronca R
    Pharmacol Res; 2016 May; 107():172-185. PubMed ID: 27013279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.